INTERNATIONAL PATENT: OMNILINX THERAPEUTICS AG FILES APPLICATION FOR "ENDOCYTIC AND SCAVENGER RECEPTOR-TARGETING CHIMERIC PROTEINS AND USES THEREOF"

GENEVA, Feb. 3 -- OMNILINX THERAPEUTICS AG (Grabenstrasse 38952 Schlieren) filed a patent application (PCT/EP2024/071329) for "ENDOCYTIC AND SCAVENGER RECEPTOR-TARGETING CHIMERIC PROTEINS AND USES THEREOF" on Jul 26, 2024. With publication no. WO/2025/021993, the details related to the patent application was published on Jan 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FARIDMOAYER, Amirreza (Nigristweg 58102 Oberengstringen), FOLLADOR, Rainer (Beckhammer 248057 Zurich)

Abstract: Chimeric proteins that bind to scavenger receptors (ScaR) or endocytic receptors (EnyR) and a target pro...